100 cancer treatments

100 cancer treatments
100 cancer treatments, organized by modality. Cancer care today spans surgical procedures, radiation techniques, cytotoxic drugs, molecularly targeted agents, immunotherapies, hormone therapies, local ablative methods and advanced cellular/gene‑based approaches—offering over a hundred distinct options tailored to tumor type and patient needs Comprehensive Cancer Information.
Main Categories of Cancer Treatment
Cancer therapies are broadly classified into:
-
Surgery: physically removing tumors Comprehensive Cancer Information
-
Radiation Therapy: using high‑energy rays to kill cancer cells Comprehensive Cancer Information
-
Chemotherapy: systemic cytotoxic drugs that target rapidly dividing cells Comprehensive Cancer Information
-
Targeted Therapy: agents that inhibit specific molecular drivers of tumor growth Comprehensive Cancer Information
-
Immunotherapy: harnessing or modulating the immune system to attack cancer Comprehensive Cancer Information
-
Hormone Therapy: blocking hormones that fuel certain cancers Comprehensive Cancer Information
-
Local Ablative Techniques: minimally invasive destruction of tumors in situ
-
Stem‑Cell Transplant & Advanced Cellular/Gene Therapies: replacing or engineering patient cells to eradicate malignancy Comprehensive Cancer Information
1. Surgical Procedures
-
Mastectomy
-
Lumpectomy
-
Prostatectomy
-
Lobectomy (lung)
-
Craniotomy for brain tumors
-
Colectomy
-
Whipple procedure (pancreaticoduodenectomy)
-
Nephrectomy
2. Radiation Therapies
-
External Beam Radiation Therapy
-
Intensity‑Modulated Radiation Therapy (IMRT)
-
Stereotactic Radiosurgery (SRS)
-
Stereotactic Body Radiation Therapy (SBRT)
-
Proton Therapy
-
Brachytherapy (internal radiation)
-
Intraoperative Radiation Therapy (IORT)
3. Chemotherapy Agents
(Categorized per major classes training.seer.cancer.gov)
16. Cyclophosphamide
17. Ifosfamide
18. Cisplatin
19. Carboplatin
20. Oxaliplatin
21. Doxorubicin
22. Daunorubicin
23. Epirubicin
24. Mitoxantrone
25. Methotrexate
26. Fluorouracil (5‑FU)
27. Capecitabine
28. Gemcitabine
29. Cytarabine
30. Vincristine
31. Vinblastine
32. Paclitaxel
33. Docetaxel
34. Etoposide
35. Topotecan
36. Irinotecan
37. Bleomycin
38. Busulfan
39. Melphalan
40. Chlorambucil
41. Pemetrexed
42. Temozolomide
43. Bendamustine
44. Procarbazine
45. L‑asparaginase
4. Targeted Therapies
(Select FDA‑approved agents Comprehensive Cancer Information)
46. Imatinib
47. Nilotinib
48. Erlotinib
49. Gefitinib
50. Cetuximab
51. Panitumumab
52. Trastuzumab
53. Pertuzumab
54. Lapatinib
55. Ado‑trastuzumab emtansine
56. Bevacizumab
57. Ramucirumab
58. Sunitinib
59. Sorafenib
60. Pazopanib
61. Axitinib
62. Regorafenib
63. Vemurafenib
64. Dabrafenib
65. Trametinib
66. Idelalisib
67. Ibrutinib
68. Osimertinib
69. Palbociclib
70. Everolimus
5. Immunotherapies
(Checkpoint inhibitors, CAR‑T, vaccines Comprehensive Cancer Information Comprehensive Cancer Information)
71. Pembrolizumab
72. Nivolumab
73. Ipilimumab
74. Atezolizumab
75. Durvalumab
76. Avelumab
77. Tisagenlecleucel (CAR‑T)
78. Axicabtagene ciloleucel (CAR‑T)
79. Talimogene laherparepvec (T‑VEC)
80. Sipuleucel‑T
6. Hormone Therapies
(Block endocrine‑driven cancers Comprehensive Cancer Information)
81. Tamoxifen
82. Letrozole
83. Anastrozole
84. Exemestane
85. Fulvestrant
86. Abiraterone
87. Enzalutamide
88. Leuprolide
7. Local Ablation & Embolic Techniques
(Non‑surgical tumor destruction)
89. Radiofrequency Ablation
90. Cryoablation
91. Transarterial Chemoembolization (TACE)
92. Radioembolization (Y‑90)
93. Photodynamic Therapy
94. High‑Intensity Focused Ultrasound (HIFU)
95. Laser Ablation
Unveiling the 50 Most Common Chronic Diseases
8. Stem‑Cell Transplant & Advanced Cellular/Gene Therapies
(Cutting‑edge curative‑intent approaches Comprehensive Cancer Information)
96. Autologous Stem Cell Transplant
97. Allogeneic Stem Cell Transplant
98. Bispecific T‑Cell Engager (e.g., Blinatumomab)
99. Antibody–Drug Conjugate (e.g., Brentuximab vedotin)
100. Cancer Vaccine Therapy
All treatments above reflect current FDA‑approved or widely practiced modalities, drawn from National Cancer Institute resources, SEER training materials, and leading oncologic registries Comprehensive Cancer InformationAnticancer Fundtraining.seer.cancer.govcancertherapyadvisor.com.
100 Most Common Types of Cancer
-
cancer treatment
-
cancer therapy
-
chemotherapy
-
radiation therapy
-
immunotherapy
-
targeted therapy
-
hormone therapy
-
CAR‑T therapy
-
stem cell transplant
-
surgical oncology
-
precision medicine
-
personalized cancer treatment
-
palliative care
-
cancer treatment side effects
-
cancer drug therapy
-
combination therapy
-
clinical trial
-
oncology treatment center
-
novel cancer drugs
-
cancer care guidelines
-
pediatric cancer treatment
-
breast cancer treatment
-
lung cancer treatment
-
prostate cancer treatment
-
colorectal cancer treatment
-
melanoma treatment
-
lymphoma treatment
-
multiple myeloma treatment
-
pancreatic cancer treatment
-
ovarian cancer treatment
-
head and neck cancer treatment
-
leukemia treatment
-
hepatocellular carcinoma treatment
-
renal cell carcinoma treatment
-
cancer immunotherapy drugs
-
checkpoint inhibitors
-
PD‑1 inhibitors
-
PD‑L1 inhibitors
-
CTLA‑4 inhibitors
-
cancer vaccines
-
oncolytic virus
-
T‑cell therapy
-
adoptive cell transfer
-
monoclonal antibodies
-
bispecific antibodies
-
ADC therapy
-
anti‑angiogenesis therapy
-
cancer nanomedicine
-
photodynamic therapy
-
hyperthermia cancer treatment
-
cryoablation
-
radiofrequency ablation
-
microwave ablation
-
irreversible electroporation
-
brachytherapy
-
systemic therapy
-
neoadjuvant therapy
-
adjuvant therapy
-
salvage therapy
-
maintenance therapy
-
consolidation therapy
-
salvage radiotherapy
-
stereotactic radiosurgery (SRS)
-
stereotactic body radiotherapy (SBRT)
-
proton beam therapy
-
heavy ion therapy
-
photothermal therapy
-
immunomodulators
-
targeted small molecules
-
kinase inhibitors
-
PARP inhibitors
-
CDK4/6 inhibitors
-
mTOR inhibitors
-
tyrosine kinase inhibitors
-
MEK inhibitors
-
BRAF inhibitors
-
EGFR inhibitors
-
HER2‑targeted therapy
-
VEGF inhibitors
-
angiogenesis inhibitors
-
protein kinase inhibitors
-
personalized oncology
-
molecular profiling
-
genomic testing
-
biomarker‑driven therapy
-
precision oncology
-
liquid biopsy
-
minimal residual disease
-
prophylactic surgery
-
reconstructive oncology
-
supportive care
-
cancer survivorship
-
quality of life
-
second‑line therapy
-
third‑line therapy
-
immuno‑oncology combination
-
chemo‑immunotherapy
-
targeted‑immunotherapy
-
chemo‑radiation therapy
-
cancer treatment costs
-
multidisciplinary care